Clinical Trial Update: Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial by Abbott evaluated adding Depakote ER to an atypical antipsychotic versus an atypical antipsychotic alone for schizophrenia; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Atypical antipsychotic
• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: Abbott | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED